Drug Type Therapeutic vaccine |
Synonyms CALRLong36 exon 9 mutant peptide vaccine, Exon 9 mutated peptide + Montanide ISA-51 |
Target- |
Action stimulants |
Mechanism Cytotoxic T lymphocytes stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myeloproliferative Disorders | Phase 1 | - | - | |
Myeloproliferative Disorders | Discovery | Denmark | - | - |
Phase 2 | 21 | jkzpouifju(cgceetoqgv) = scdxlekcbb reqyblsscr (midnruopva ) View more | - | 20 Jun 2007 | |||
(Peptide-pulsed dendritic cells given intravenously) | jkzpouifju(cgceetoqgv) = gcdmjzxpuv reqyblsscr (midnruopva ) View more |